<DOC>
<DOCNO>EP-0619814</DOCNO> 
<TEXT>
<INVENTION-TITLE>
OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3141	A61K3141	A61K314245	A61K314245	A61K31445	A61K31445	A61P2500	A61P2528	A61P2700	A61P2716	A61P4300	A61P4300	C07D27100	C07D27106	C07D27110	C07D41300	C07D41306	C07D41312	C07D41314	C07D45300	C07D45302	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P25	A61P25	A61P27	A61P27	A61P43	A61P43	C07D271	C07D271	C07D271	C07D413	C07D413	C07D413	C07D413	C07D453	C07D453	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Heterocyclic compounds of the formula: R
<
1
>
-Q-Z-X-A-M, wherein R
<
1
>
 is lower alkyl, a heterocyclic group which may have suitable substituent(s), etc; Q is oxadiazolediyl, Z is bond or vinyl, X is bond, a group of formula (a), (in which R
<
4
>
 is hydrogen or lower alkyl), a group of formula (b), (in which R
<
8
>
 is hydroxy or protected hydroxy), etc; A is bond, lower alkylene or lower alkynylene and M is a heterocyclic group containing at least one nitrogen atom which may have one substituent selected from the group consisting of lower alkyl, an imino protective group and ar(lower)alkyl which may have suitable substituent(s), and a pharmaceutically acceptable salt thereof which are useful as a medicament.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
 DESCRIPTIONOXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINI AGONIST ACTIVITYTECHNICAL FIELDThis invention relates to new heterocyclic compounds and pharmaceutically acceptable salts thereof which are useful as a medicament.DISCLOSURE OF INVETIONThis invention relates to new heterocyclic compounds. More particularly, this invention relates to new oxadiazole derivatives and pharmaceutically acceptable salts thereof which have pharmacological activities, processes for preparation thereof, a pharmaceutical composition comprising the same and a use of the same.Accordingly, one object of this invention is to provide the new and useful oxadiazole derivatives and pharmaceutically acceptable salts thereof which possess an acetylcholinesterase-inhibitory activity and muscarinic agonist activity.Another object of this invention is to provide processes for preparation of the oxadiazole derivatives and their salts thereof.A further object of this invention is to provide a pharmaceutical composition comprising said oxadiazole derivatives or a pharmaceutically acceptable salt thereof. Still further object of this invention is to provide a use of said oxadiazole derivative or a pharmaceutically 

 acceptable salt thereof as a medicament for prophylactic and therapeutic treatment of disorders in the central nervous system such as amnesia, dementia [e.g. senile dementia of Alzheimer type, vascular dementia etc.], cerebrovascular disease, in human being and animals.The object oxadiazole derivatives of the present invention are novel and represented by the following general formula (I) :-Z— —A—M (I)wherein R is lower alkyl, a heterocyclic group which may have suitable substituent(s), aryl which may have suitable substituent i s) , ar(lower)alkyl which may have suitable substituent(s) , or ar(lower)alkenyl which may have suitable substituent(s) , Q is oxadiazolediyl, z is bond or vinyl,X is bond, a group of the formula :4 (in which R is hydrogen or lower alkyl) , a group of the formula : R8 -CH-{ {iinn wwhhiicchh R is hydroxy or protected hydroxy) ,0!l-C- or 

 ___ _-NHCO- A is bond, lower alkylene or lower alkynylene and M is a heterocyclic group containing at least one nitrogen atom which may have one substituent selected from the group consisting of lower alkyl, an imino protective group and ar(lower)alkyl which may have suitable substituent(s) .The object compound (I) of the present invention can be prepared by the following processes.Process (1)3—COOH(ID or its reactive derivative at the
</DESCRIPTION>
<CLAIMS>
C L I M S
A compound of the formula :
-Z — X — — M
wherein R is lower alkyl, a heterocyclic group which may have suitable substituent(s), aryl which may have suitable substituent(s) , ar(lower)alkyl which may have suitable substituent(s), or ar(lower)alkenyl which may have suitable substituent(s) , Q is oxadiazolediyl, Z is bond or vinyl, X is bond, a group of the formula :
(in which R is hydrogen or lower alkyl) , a group of the formula :

 o
(in which R is hydroxy or protected hydroxy) ,
O
II -C- or
-NHCO- 


 A is bond, lower alkylene or lower alkynylene and
M is a heterocyclic group containing at least one nitrogen atom which may have one substituent selected from the group consisting of lower alkyl, an imino protective group and ar(lower) lkyl which may have suitable substituent(s) , and a pharmaceutically acceptable salt thereof.
2. A compound of claim 1, wherein «1 is lower alkyl, a heterocyclic group which may have 1 to 3 suitable substituent(s) , aryl which may have 1 to 3 substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, nitro, halogen, mono(or di or tri)halo(lower)alkyl, lower alkylthio, lower alkylsulfinyl, cyano and acyl, ar(lower)alkyl which may have 1 to 3 substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, nitro, mono(or di or tri)halo(lower)alkyl, cyano, lower alkylthio, lower alkylsulfinyl and lower alkylsulfonyl, or ar(lower)alkenyl which may have 1 to 3 substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, nitro, mono(or di or tri)halo(lower)alkyl, cyano, lower alkylthio, lower alkylsulfinyl and lower alkylsulfonyl.

 X is bond, a group of the formula
-CON-
(in which R is hydrogen or lower alkyl), a group of the formula :
(in which R is hydroxy or acyloxy) ,
O
II -C- or
-NHCO- , and
M is unsaturated 5 or 6-membered heteromonocyclic group containing 1 to 4-nitrogen atom(s) or saturated 5 or 6-membered heteromonocyclic group containing 1 to 4 nitrogen atom(s), each of which may have one substituent selected from the group consisting of lower alkyl, an imino protective group and ar{lower)alkyl which may have 1 to 3 suitable substituen (s) .
3. A compound of the claim 2, wherein - 1
"
R is lower alkyl; unsaturated 5 or 6-membered heteromonocyclic group containing 1 to 4 nitrogen atom(s), unsaturated 5 or 6-membered heteromonocyclic group containing 1 to 2 sulfur atom(s) or saturated heterobicyclic group of the formula : 


 (wherein Jt, in and n are each integer of 1 to 3), 

each of which may have 1 to 2 substituent(s) selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, lower alkoxy, lower alkylthio, lower alkylsulfinyl,
10 cyano, nitro, mono(or di or tri) alo(lower)alkyl and acyl; phenyl which may have 1 to 2 substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, nitro, halogen, mono(or di
15 or tri )halo(lower)alkyl, lower alkylthio, lower alkylsulfinyl, cyano, lower alkylsulfonyl and lower alkanoyl; phenyl(lower)alkyl which may have 1 to 2 substituent(s) selected from the group
20 consisting of lower alkyl, lower alkoxy, nitro, mono(or di or tri)halo(lower)alkyl, cyano, lower alkylthio, lower alkylsulfinyl and lower alkylsulfonyl; or phenyl(lower)alkenyl which may have 1 to 2
25 substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, nitro, mono(or di or tri)halo(lower)alkyl, cyano, lower alkylthio, lower alkylsulfinyl and lower alkylsulfonyl,
30 x is bond, a group of the formula :
R
4
-CON-
35 


 (in which R is hydrogen or lower alkyl), a group of the formula :
Q
(in which R is hydroxy or lower alkanoyloxy) ,
O II -C- or
-NHCO- , and
M is piperidyl, piperazinyl, pyrrolidinyl, tetrahydropyridyl or pyridyl, each of which may have one substituent selected from the group consisting of lower alkyl, acyl and phenyl(lower)alkyl which may have 1 to 2 substituent(s) selected from the group consisting of halogen, cyano, nitro, lower alkyl, lower alkoxy and lower alkylthio.
4. A compound of claim 3, wherein
R is lower alkyl; pyridyl, thienyl or guinuclidinyl, each of which may have cyano; phenyl which may have a substituent selected from the group consisting of lower alkyl, lower alkoxy, nitro, halogen, mono(or di or tri)halo(lower)alkyl, lower alkylthio, lower alkylsulfinyl, cyano, lower alkylsulfonyl and lower alkanoyl; phenyl(lower)alkyl which may have nitro; or phenyl(lower)alkenyl which may have cyano or nitro, and M is piperidyl, piperazinyl, pyrrolidinyl, 


 tetrahydropyridyl or pyridyl, each of which may have one substituent selected from the group consisting of lower alkyl, lower alkoxycarbonyl and phenyl(lower)alkyl which may have a substituent selected from the group consisting of halogen, cyano, nitro, lower alkyl and lower alkoxy.
5. A compound of the claim 4, wherein R is phenyl which may have a substituent selected from the group consisting of lower alkyl, lower alkoxy, nitro, halogen, mono(or di or tri)- halo(lower)alkyl, lower alkylthio, lower alkylsulfinyl, cyano, lower alkylsulfonyl and lower alkanoyl.
(in which R is hydrogen).
A is lower alkylene, and
M is piperidyl which has phenyl(lower)alkyl which may have a substituent selected from the group consisting of halogen, cyano, nitro, lower alkyl and lower alkoxy. 


 6- A compound of claim 5, which is a compound of the formula :
wherein R is cyanophenyl,
A is lower alkylene, and M is piperidyl having halophenyKlower)- alkyl.
7. A compound of claim 6, which is selected from the group consisting of :
3-[[2-{l-(4-Fluorobenzyl)piperidin-4-yl}ethyl]- carbamoyl]
-5-(4-cyanophenyl)-1 , 2 ,4-oxadiazole fumarate,
3-[[2-{l-{3-Fluorobenzyl)piperidin-4-yl}ethyl]- carbamoyl]
-5-(4-cyanophenyl)-1,2,4-oxadiazole fumarate,
3-[[2-{l-(2-Fluorobenzyl)piperidin-4-yl}ethyl]- carbamoyl]
-5-(4-cyanophenyl)-1,2,4-oxadiazole fumarate,
3-[[2-{l-(4-Chlorobenzyl)piperidin-4-yl}ethyl]- carbamoyl]
-5-(4-cyanophenyl)-1,2,4-oxadiazole fumarate and
3-[[2-{l-(4-Fluorobenzyl)piperidin-4-yl}ethyl]- carbamoyl]
-5-(4-cyanophenyl)-1,2,4-oxadiazole hydrochloride. 


8. A process for preparing a compound of the formula :
-Z— —A—M
wherein R
x
 is lower alkyl, a heterocyclic group which may have suitable substituent(s) , aryl which may have suitable substituent(s) , ar(lower)alkyl which may have suitable substituent(s), or ar(lower)alkenyl which may have suitable substituent(s) ,
Q is oxadiazolediyl,
Z is bond or vinyl,
X is bond, a group of the formula :
R
4
!
-CON-
(in which R is hydrogen or lower alkyl), a group of the formula :

 o (in which R is hydroxy or protected hydroxy) ,
O
II -C- or
-NHCO-
is bond, lower alkylene or lower alkynylene and 


 M is a heterocyclic group containing at least one nitrogen atom which may have one substituent selected from the group consisting of lower alkyl, an imino protective group and ar(lower)alkyl which may have suitable substituent(s) , or a salt thereof, which comprises (1) reacting a compound of the formula :
-Z—COOH
wherein R , 0 and Z are each as defined above, or its reactive derivative at the carboxy group, or a salt thereof with a compound of the formula :
H
2
N—A—M
wherein A and M are each as defined above, or its reactive derivative at the amino group, or a salt thereof to give a compound of the formula
-Z—CONH—A—
wherein R , Q, Z, A and M are each as defined above, or a salt thereof, or (2) reacting a compound of the formula :
wherein R , 0 and Z are each as defined above, or its reactive derivative at the amino group, or a salt thereof with a compound of the formula 


 O
I
HO — C — A — M
wherein A and M are each as defined above, or its reactive derivative at the carboxy group, or a salt thereof to give a compound of the formula
-NHCO—A—M
wherein R1, Q, Z, A and M are each as defined above, or a salt thereof, or
(3) reacting a compound of the formula :
1 " -R-
wherein R is as defined above, and 3 R is a leaving group, or a salt thereof with a compound of the formula :
N~OH II H
2
N—C—Z— —A—
wherein Z, X, A and M are each as defined above, or a salt thereof to give a compound of the formula
wherein R , Z, X, A and M are each as defined above, or a salt thereof, or (4) reacting a compound of the formula : 


 -Z — CONH — A— M
wherein R , Q, Z, A and M are each as defined above, or a salt thereof with a compound of the formula :
- i
1
4 wherein R_ is lower alkyl, and Y 1 is acid residue, or a salt thereof to give a compound of the formula :
wherein R1, Q, Z, Rc_l, A and M are each as defined above, or a salt thereof, or (5) subjecting a compound of the formula :
wherein R , Q, Z, X and A are each as defined above,
R7 is hydrogen, (C--C
5
)alkyl, aryl which may have suitable substituent(s), or ar(C.-C
c
)alkyl which may have suitable

 i i i and ^ is anion, or a salt thereof to reduction reaction to give a compound of the formula : 


 wherein R , R , Q, Z, X, A and —- NH are each as defined above, or a salt thereof, or
(6) subjecting a compound of the formula :
R
1
—Q—Z—X—A—M
1
wherein R , Q, Z, X and A are each as defined above, and M is a heterocyclic group containing at least one nitrogen atom which has an imino protective group, or a salt thereof to elimination reaction of the imino protective group to give a compound of the formula :
R
1
—Q—Z—X—A—M
2
wherein R , Q, Z, X and A are each as defined above, and
M 2 i.s a heterocyclic group containing at least one nitrogen atom, or a salt thereof, or (7) subjecting a compound of the formula :
wherein R , Q, Z, X and A are each as defined above, 2 R is lower alkyl, an immo protective group, or ar(lower)alkyl which may have suitable substituent(s) , and W
2
® is anion. 


 or a salt thereof to reduction reaction to give a compound of the formula :
wherein R 1, Q, Z, X, A and R2 are each as defined above, or a salt thereof, or (8) subjecting a compound of the formula :
wherein R , Q, Z, A and M are each as defined above, and o
R S
=
i is protected hydroxy. or a salt thereof to elimination reaction of the hydroxy protective group to give a compound of the formula :
R
1
—Q— —CH—A—
OH
wherein R , Q, Z, A and M are each as defined above, or a salt thereof, or (9) subjecting a compound of the formula
R
1
—Q— —CH-A-M
OH
wherein R , Q, Z, A and M are each as defined above, or a salt thereof to oxidation reaction to give a compound of the formula : 

wherein R , Q, Z, A and M are each as defined above, or a salt thereof, or (10) reacting a compound of the formula :
wherein R1, Q, Z and X are each as defined above, or a salt thereof with a compound of the formula
wherein R and H- NH are each as defined above, and VT® is anion, or a salt thereof to give a compound of the formula
wherein R 1, Q, Z, X, R""
>
 and are each as 


 defined above, or a salt thereof.
9. A pharmaceutical composition which comprises, as an active ingredient, a compound of claim 1 or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers. 


 10. A use of a compound of claim 1 or a pharmaceutically acceptable salt thereof as acetylcholinesterase- irihibitory agent or muscarinic agonist.
11. A method for the prophylactic or therapeutic treatment of disorders in the central nervous system and cerebrovascular disease which comprises administering a compound of claim 1 or a pharmaceutically acceptable salt thereof to human or animals.
12. A process for preparing a pharmaceutical composition which comprises admixing a compound of claim 1 or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable carrier. 

</CLAIMS>
</TEXT>
</DOC>
